Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders (original) (raw)

• Centers for Disease Prevention and Control. Smoking-attributable mortality, years of potential life lost, and productivity losses: United States, 2000–2004. MMWR. 2008;57(45):1226–8.
  Google Scholar
• National Drug Intelligence Center. The economic impact of illicit drug use on American society. Washington, D.C.: United States Department of Justice; 2011.
  Google Scholar
• Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373(9682):2223–33.
  Article PubMed Google Scholar
• Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: summary of national findings. Rockville: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration; 2012.
• Centers for Disease Prevention and Control. Vital signs: current cigarette smoking among adults aged ≥18 years: United States, 2005–2010. MMWR. 2011;60(35):1207–12.
  Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.
  Google Scholar
• Dole VP, Nyswander M. A medical treatment for diacetylmorphine (Heroin) addiction: a clinical trial with methadone hydrochloride. JAMA. 1965;193(Journal Article):646–50.
  Article CAS PubMed Google Scholar
• van den Brink W, Haasen C. Evidenced-based treatment of opioid-dependent patients. Can J Psychiatry. 2006;51(10):635–46.
  PubMed Google Scholar
• Fiore MC, Jaén CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. May 2008.
• van den Brink W. Evidence-based pharmacological treatment of substance use disorders and pathological gambling. Curr Drug Abuse Rev. 2012;5(1):3–31.
  Article PubMed Google Scholar
• Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;5:CD009329.
  PubMed Google Scholar
• Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):47–55.
  Article CAS PubMed Google Scholar
• Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):56–63.
  Article CAS PubMed Google Scholar
• Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, et al. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Int Med. 2006;166(15):1571–7.
  Article CAS Google Scholar
• Rosner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M. Acamprosate for alcohol dependence. Cochrane Database Syst Rev. 2010;(9):CD004332.
• Rosner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev. 2010;(12):CD001867.
• Vandrey R, Haney M. Pharmacotherapy for cannabis dependence: how close are we? CNS Drugs. 2009;23(7):543–53.
  Article CAS PubMed Central PubMed Google Scholar
• Weinstein AM, Gorelick DA. Pharmacological treatment of cannabis dependence. Curr Pharm Design. 2011;17(14):1351–8.
  Article CAS Google Scholar
• Stoops WW, Rush CR. Agonist replacement for stimulant dependence: a review of clinical research. Curr Pharm Design. 2013;19(40):7026–35.
  Google Scholar
• Kalivas PW, Lalumiere RT, Knackstedt L, Shen H. Glutamate transmission in addiction. Neuropharmacology. 2009;56 Suppl 1:169–73.
  Article PubMed Google Scholar
• Kalivas PW, Volkow ND. New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry. 2011;16(10):974–86.
  Article CAS PubMed Central PubMed Google Scholar
• Berk M, Malhi GS, Gray LJ, Dean OM. The promise of _N_-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci. 2013;34(3):167–77.
  Article CAS PubMed Google Scholar
• Brown RM, Kupchik YM, Kalivas PW. The story of glutamate in drug addiction and of _N_-acetylcysteine as a potential pharmacotherapy. JAMA Psychiatry. 2013;70:895–7.
  Article CAS PubMed Google Scholar
• Dodd S, Dean O, Copolov DL, Malhi GS, Berk M. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther. 2008;8(12):1955–62.
  Article CAS PubMed Google Scholar
• Borgstrom L, Kagedal B, Paulsen O. Pharmacokinetics of _N_-acetylcysteine in man. Eur J Clin Pharmacol. 1986;31(2):217–22.
  Article CAS PubMed Google Scholar
• Olsson B, Johansson M, Gabrielsson J, Bolme P. Pharmacokinetics and bioavailability of reduced and oxidized _N_-acetylcysteine. Eur J Clin Pharmacol. 1988;34(1):77–82.
  Article CAS PubMed Google Scholar
• Grandjean EM, Berthet P, Ruffmann R, Leuenberger P. Efficacy of oral long-term _N_-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials. Clin Ther. 2000;22(2):209–21.
  Article CAS PubMed Google Scholar
• Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Resp Crit Care Med. 1997;156(2 Pt 1):341–57.
  Article CAS PubMed Google Scholar
• Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988;319(24):1557–62.
  Article CAS PubMed Google Scholar
• Dippy JE, Davis SS. Rheological assessment of mucolytic agents on sputum of chronic bronchitis. Thorax. 1969;24(6):707–13.
  Article CAS PubMed Google Scholar
• Bailey B, McGuigan MA. Management of anaphylactoid reactions to intravenous _N_-acetylcysteine. Ann Emerg Med. 1998;31(6):710–5.
  Article CAS PubMed Google Scholar
• Mant TG, Tempowski JH, Volans GN, Talbot JC. Adverse reactions to acetylcysteine and effects of overdose. Br Med J (Clinical Res Ed). 1984;289(6439):217–9.
  Article CAS Google Scholar
• Bailey B, Blais R, Letarte A. Status epilepticus after a massive intravenous _N_-acetylcysteine overdose leading to intracranial hypertension and death. Ann Emerg Med. 2004;44(4):401–6.
  Article PubMed Google Scholar
• Marzullo L. An update of _N_-acetylcysteine treatment for acute acetaminophen toxicity in children. Curr Opin Pediatr. 2005;17(2):239–45.
  Article PubMed Google Scholar
• Mucomyst [package insert]. New York City (NY): Bristol-Myers Squibb Company; 2007.
• Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008;11(6):851–76.
  Article CAS PubMed Google Scholar
• Atkuri KR, Mantovani JJ, Herzenberg LA. _N_-Acetylcysteine: a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007;7(4):355–9.
  Article CAS PubMed Google Scholar
• Berk M, Ng F, Dean O, Dodd S, Bush AI. Glutathione: a novel treatment target in psychiatry. Trends Pharmacol Sci. 2008;29(7):346–51.
  Article CAS PubMed Google Scholar
• Seiva FR, Amauchi JF, Rocha KK, Ebaid GX, Souza G, Fernandes AA, et al. Alcoholism and alcohol abstinence: _N_-acetylcysteine to improve energy expenditure, myocardial oxidative stress, and energy metabolism in alcoholic heart disease. Alcohol. 2009;43(8):649–56.
  Article CAS PubMed Google Scholar
• Ozaras R, Tahan V, Aydin S, Uzun H, Kaya S, Senturk H. _N_-acetylcysteine attenuates alcohol-induced oxidative stress in the rat. World J Gastroenterol. 2003;9(1):125–8.
  CAS PubMed Google Scholar
• Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009;10(8):561–72.
  Article CAS PubMed Google Scholar
• Olive MF, Cleva RM, Kalivas PW, Malcolm RJ. Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacol Biochem Behav. 2012;100(4):801–10.
  Article CAS PubMed Central PubMed Google Scholar
• Palmatier MI, Liu X, Donny EC, Caggiula AR, Sved AF. Metabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotine. Neuropsychopharmacology. 2008;33(9):2139–47.
  Article CAS PubMed Central PubMed Google Scholar
• Gipson CD, Reissner KJ, Kupchik YM, Smith AC, Stankeviciute N, Hensley-Simon ME, et al. Reinstatement of nicotine seeking is mediated by glutamatergic plasticity. Proc Natl Acad Sci U S A. 2013;110(22):9124–9.
  Article CAS PubMed Central PubMed Google Scholar
• LaLumiere RT, Kalivas PW. Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci. 2008;28(12):3170–7.
  Article CAS PubMed Google Scholar
• McFarland K, Lapish CC, Kalivas PW. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci. 2003;23(8):3531–7.
  CAS PubMed Google Scholar
• Knackstedt LA, LaRowe S, Mardikian P, Malcolm R, Upadhyaya H, Hedden S, et al. The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol Psychiatry. 2009;65(10):841–5.
  Article CAS PubMed Central PubMed Google Scholar
• Knackstedt LA, Melendez RI, Kalivas PW. Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry. 2010;67(1):81–4.
  Article CAS PubMed Central PubMed Google Scholar
• Rao PS, Sari Y. Glutamate transporter 1: target for the treatment of alcohol dependence. Curr Med Chem. 2012;19(30):5148–56.
  Article CAS PubMed Central PubMed Google Scholar
• Baker DA, McFarland K, Lake RW, Shen H, Toda S, Kalivas PW. _N_-acetyl cysteine-induced blockade of cocaine-induced reinstatement. Ann N Y Acad Sci. 2003;1003:349–51.
  Article PubMed Google Scholar
• Pierce RC, Bell K, Duffy P, Kalivas PW. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci. 1996;16(4):1550–60.
  CAS PubMed Google Scholar
• Berglind WJ, Whitfield TW Jr, LaLumiere RT, Kalivas PW, McGinty JF. A single intra-PFC infusion of BDNF prevents cocaine-induced alterations in extracellular glutamate within the nucleus accumbens. J Neurosci. 2009;29(12):3715–9.
  Article CAS PubMed Central PubMed Google Scholar
• Knackstedt LA, Moussawi K, Lalumiere R, Schwendt M, Klugmann M, Kalivas PW. Extinction training after cocaine self-administration induces glutamatergic plasticity to inhibit cocaine seeking. J Neurosci. 2010;30(23):7984–92.
  Article CAS PubMed Central PubMed Google Scholar
• Wang X, Moussawi K, Knackstedt L, Shen H, Kalivas PW. Role of mGluR5 neurotransmission in reinstated cocaine-seeking. Addict Biol. 2013;18(1):40–9.
  Article PubMed Central PubMed Google Scholar
• Gipson CD, Kupchik YM, Kalivas PW. Rapid, transient synaptic plasticity in addiction. Neuropharmacology. 2014;76 Pt B:276–86.
  Article PubMed Google Scholar
• Gipson CD, Kupchik YM, Shen H, Reissner KJ, Thomas CA, Kalivas PW. Relapse induced by cues predicting cocaine depends on rapid, transient synaptic potentiation. Neuron. 2013;77(5):867–72.
  Article CAS PubMed Google Scholar
• Shen HW, Gipson CD, Huits M, Kalivas PW. Prelimbic cortex and ventral tegmental area modulate synaptic plasticity differentially in nucleus accumbens during cocaine-reinstated drug seeking. Neuropsychopharmacology. Epub 15 Nov 2013. Doi: 10.1038/npp.2013.318.
• Williams SM, Sullivan RK, Scott HL, Finkelstein DI, Colditz PB, Lingwood BE, et al. Glial glutamate transporter expression patterns in brains from multiple mammalian species. Glia. 2005;49(4):520–41.
  Article PubMed Google Scholar
• Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S, et al. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci. 2003;6(7):743–9.
  Article CAS PubMed Google Scholar
• Carlisle HJ, Kennedy MB. Spine architecture and synaptic plasticity. Trends Neurosci. 2005;28(4):182–7.
  Article CAS PubMed Google Scholar
• De Roo M, Klauser P, Muller D. LTP promotes a selective long-term stabilization and clustering of dendritic spines. PLoS Biol. 2008;6(9):e219.
  Article PubMed Central PubMed Google Scholar
• Yang Y, Zhou Q. Spine modifications associated with long-term potentiation. Neuroscientist. 2009;15(5):464–76.
  Article CAS PubMed Google Scholar
• Moussawi K, Zhou W, Shen H, Reichel CM, See RE, Carr DB, et al. Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse. Proc Natl Acad Sci U S A. 2011;108(1):385–90.
  Article CAS PubMed Central PubMed Google Scholar
• Matsuzaki M, Honkura N, Ellis-Davies GC, Kasai H. Structural basis of long-term potentiation in single dendritic spines. Nature. 2004;429(6993):761–6.
  Article CAS PubMed Google Scholar
• Kalivas PW, McFarland K, Bowers S, Szumlinski K, Xi ZX, Baker D. Glutamate transmission and addiction to cocaine. Ann N Y Acad Sci. 2003;1003:169–75.
  Article CAS PubMed Google Scholar
• Gipson CD, Kupchik YM, Shen H, Reissner KJ, Thomas CA, Kalivas PW. Relapse induced by cues predicting cocaine depends on rapid, transient synaptic potentiation. Neuron. 2013;77:867–72.
  Article CAS PubMed Google Scholar
• Yin HH, Knowlton BJ. The role of the basal ganglia in habit formation. Nat Rev Neurosci. 2006;7(6):464–76.
  Article CAS PubMed Google Scholar
• Groenewegen HJ, Wright CI, Beijer AV. The nucleus accumbens: gateway for limbic structures to reach the motor system? Prog Brain Res. 1996;107:485–511.
  Article CAS PubMed Google Scholar
• Koob GF. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction. 2006;101(Suppl 1):23–30.
  Article PubMed Google Scholar
• Peters J, LaLumiere RT, Kalivas PW. Infralimbic prefrontal cortex is responsible for inhibiting cocaine seeking in extinguished rats. J Neurosci. 2008;28(23):6046–53.
  Article CAS PubMed Central PubMed Google Scholar
• Anderson SM, Famous KR, Sadri-Vakili G, Kumaresan V, Schmidt HD, Bass CE, et al. CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking. Nat Neurosci. 2008;11(3):344–53.
  Article CAS PubMed Google Scholar
• Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, et al. The cystine/glutamate antiporter system x(c)(−) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013;18(5):522–55.
  Article CAS PubMed Google Scholar
• Dringen R, Gutterer JM, Gros C, Hirrlinger J. Aminopeptidase N mediates the utilization of the GSH precursor CysGly by cultured neurons. J Neurosci Res. 2001;66(5):1003–8.
  Article CAS PubMed Google Scholar
• Kupchik YM, Moussawi K, Tang XC, Wang X, Kalivas BC, Kolokithas R, et al. The effect of _N_-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine. Biol Psychiatry. 2012;71(11):978–86.
  Article CAS PubMed Central PubMed Google Scholar
• Schmaal L, Veltman DJ, Nederveen A, van den Brink W, Goudriaan AE. _N_-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study. Neuropsychopharmacology. 2012;37(9):2143–52.
  Article CAS PubMed Google Scholar
• Kalivas PW, Volkow N, Seamans J. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron. 2005;45(5):647–50.
  Article CAS PubMed Google Scholar
• Trantham-Davidson H, Lalumiere RT, Reissner KJ, Kalivas PW, Knackstedt LA. Ceftriaxone normalizes nucleus accumbens synaptic transmission, glutamate transport, and export following cocaine self-administration and extinction training. J Neurosci. 2012;32(36):12406–10.
  Article CAS PubMed Central PubMed Google Scholar
• Papouin T, Ladepeche L, Ruel J, Sacchi S, Labasque M, Hanini M, et al. Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists. Cell. 2012;150(3):633–46.
  Article CAS PubMed Google Scholar
• Conrad KL, Tseng KY, Uejima JL, Reimers JM, Heng LJ, Shaham Y, et al. Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature. 2008;454(7200):118–21.
  Article CAS PubMed Central PubMed Google Scholar
• Reichel CM, Moussawi K, Do PH, Kalivas PW, See RE. Chronic _N_-acetylcysteine during abstinence or extinction after cocaine self-administration produces enduring reductions in drug seeking. J Pharmacol Exp Ther. 2011;337(2):487–93.
  Article CAS PubMed Google Scholar
• Murray JE, Everitt BJ, Belin D. _N_-Acetylcysteine reduces early- and late-stage cocaine seeking without affecting cocaine taking in rats. Addict Biol. 2012;17(2):437–40.
  Article CAS PubMed Google Scholar
• Zhou W, Kalivas PW. _N_-acetylcysteine reduces extinction responding and induces enduring reductions in cue- and heroin-induced drug-seeking. Biol Psychiatry. 2008;63(3):338–40.
  Article CAS PubMed Central PubMed Google Scholar
• Ramirez-Nino AM, D’Souza MS, Markou A. _N_-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: comparison with the effects of _N_-acetylcysteine on food responding and food seeking. Psychopharmacology. 2013;225:473–82.
  Article CAS PubMed Central PubMed Google Scholar
• Moussawi K, Pacchioni A, Moran M, Olive MF, Gass JT, Lavin A, et al. _N_-Acetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci. 2009;12(2):182–9.
  Article CAS PubMed Central PubMed Google Scholar
• Madayag A, Lobner D, Kau KS, Mantsch JR, Abdulhameed O, Hearing M, et al. Repeated _N_-acetylcysteine administration alters plasticity-dependent effects of cocaine. J Neurosci. 2007;27(51):13968–76.
  Article CAS PubMed Central PubMed Google Scholar
• Amen SL, Piacentine LB, Ahmad ME, Li SJ, Mantsch JR, Risinger RC, et al. Repeated _N_-acetyl cysteine reduces cocaine seeking in rodents and craving in cocaine-dependent humans. Neuropsychopharmacology. 2011;36(4):871–8.
  Article CAS PubMed Google Scholar
• Gass JT, Sinclair CM, Cleva RM, Widholm JJ, Olive MF. Alcohol-seeking behavior is associated with increased glutamate transmission in basolateral amygdala and nucleus accumbens as measured by glutamate-oxidase-coated biosensors. Addict Biol. 2011;16(2):215–28.
  Article CAS PubMed Central PubMed Google Scholar
• LaRowe SD, Mardikian P, Malcolm R, Myrick H, Kalivas P, McFarland K, et al. Safety and tolerability of _N_-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2006;15(1):105–10.
  Article PubMed Central PubMed Google Scholar
• Mardikian PN, LaRowe SD, Hedden S, Kalivas PW, Malcolm RJ. An open-label trial of _N_-acetylcysteine for the treatment of cocaine dependence: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(2):389–94.
  Article CAS PubMed Google Scholar
• Gray KM, Watson NL, Carpenter MJ, Larowe SD. _N_-acetylcysteine (NAC) in young marijuana users: an open-label pilot study. Am J Addict. 2010;19(2):187–9.
  Article PubMed Central PubMed Google Scholar
• LaRowe SD, Myrick H, Hedden S, Mardikian P, Saladin M, McRae A, et al. Is cocaine desire reduced by _N_-acetylcysteine? Am J Psychiatry. 2007;164(7):1115–7.
  Article PubMed Google Scholar
• Schmaal L, Berk L, Hulstijn KP, Cousijn J, Wiers RW, van den Brink W. Efficacy of _N_-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study. Eur Addict Res. 2011;17(4):211–6.
  Article PubMed Google Scholar
• Van Schooten FJ, Besaratinia A, De Flora S, D’Agostini F, Izzotti A, Camoirano A, et al. Effects of oral administration of _N_-acetyl-l-cysteine: a multi-biomarker study in smokers. Cancer Epidemiol Biomarkers Prev. 2002;11(2):167–75.
  PubMed Google Scholar
• Grant JE, Odlaug BL, Kim SW. A double-blind, placebo-controlled study of _N_-acetyl cysteine plus naltrexone for methamphetamine dependence. Eur Neuropsychopharmacol. 2010;20(11):823–8.
  Article CAS PubMed Google Scholar
• Gray KM, Carpenter MJ, Baker NL, DeSantis SM, Kryway E, Hartwell KJ, et al. A double-blind randomized controlled trial of _N_-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012;169(8):805–12.
  Article PubMed Central PubMed Google Scholar
• Roten AT, Baker NL, Gray KM. Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial. Addict Behav. 2013;38(3):1788–91.
  Article PubMed Google Scholar
• LaRowe SD, Kalivas PW, Nicholas JS, Randall PK, Mardikian PN, Malcolm RJ. A double-blind placebo-controlled trial of _N_-acetylcysteine in the treatment of cocaine dependence. Am J Addict. 2013;22(5):443–52.
  Article PubMed Google Scholar
• Gass JT, Olive MF. Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol. 2008;75(1):218–65.
  Article CAS PubMed Central PubMed Google Scholar
• Sunitha K, Hemshekhar M, Thushara RM, Santhosh MS, Yariswamy M, Kemparaju K, et al. _N_-Acetylcysteine amide: a derivative to fulfill the promises of _N_-acetylcysteine. Free Radic Res. 2013;47(5):357–67.
  Article CAS PubMed Google Scholar
• Ferreira Seiva FR, Amauchi JF, Ribeiro Rocha KK, Souza GA, Ebaid GX, Burneiko RM, et al. Effects of _N_-acetylcysteine on alcohol abstinence and alcohol-induced adverse effects in rats. Alcohol. 2009;43(2):127–35.
  Article PubMed Google Scholar
• Holmes A, Spanagel R, Krystal JH. Glutamatergic targets for new alcohol medications. Psychopharmacology. 2013;229(3):539–54.
  Article CAS PubMed Google Scholar